ADAPTIVE BIOTECHNOLOGIES CORPORATION - COMMON STOC

10.03

05-May-25 16:45:00

15 minutes delayed

Stocks

+0.19

+1.93%

Today's range

9.47 - 10.18

ISIN

N/A

Source

NASDAQ

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results

24 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

23 Feb 2021 09:15:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

23 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

02 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

11 Jan 2021 16:01:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.